Abstract
OBJECTIVE: The purpose of this study was to estimate whether universal influenza vaccination of pregnant women was cost-effective in the management of influenza-like illness during influenza season. METHODS: A decision analysis model was developed to investigate the cost-effectiveness of providing inactivated trivalent influenza vaccine to all pregnant women. This scenario was compared with providing supportive care only on a case-by-case basis to the unvaccinated pregnant population. RESULTS: Vaccination of 100% of pregnant women would save approximately $50 per woman, resulting in a net gain of approximately 45 quality-adjusted hours relative to providing supportive care only. CONCLUSION: Universal vaccination with inactivated trivalent influenza vaccine is cost-saving relative to providing supportive care alone in the pregnant population.
Original language | English (US) |
---|---|
Pages (from-to) | 1323-1329 |
Number of pages | 7 |
Journal | Obstetrics and gynecology |
Volume | 107 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1 2006 |
Externally published | Yes |
ASJC Scopus subject areas
- Obstetrics and Gynecology